NCT07076914View on ClinicalTrials.gov

Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

October 2, 2025

Primary Completion Date

January 2, 2028

Study Completion Date

October 2, 2032

Conditions
Primary Lung CancerNon Small Cell Lung CancerSmall Cell Lung Cancer
Interventions
DRUG

Experimental (Health Canada Approved Proton Pump Inhibitors)

The intervention uses a proton pump inhibitor as a preventative measure

Trial Locations (1)

N6A5W9

London Health Sciences Centre, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER